We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Inhibition of the Sec61 translocon overcomes cytokine‐induced glucocorticoid resistance in T‐cell acute lymphoblastic leukaemia.
- Authors
Meyer, Lauren K.; Delgado‐Martin, Cristina; Sharp, Phillip P.; Huang, Benjamin J.; McMinn, Dustin; Vincent, Tiffaney L.; Ryan, Theresa; Horton, Terzah M.; Wood, Brent L.; Teachey, David T.; Taunton, Jack; Kirk, Christopher J.; Hermiston, Michelle L.
- Abstract
Glucocorticoid (GC) resistance is a poor prognostic factor in T‐cell acute lymphoblastic leukaemia (T‐ALL). Interleukin‐7 (IL‐7) mediates GC resistance via GC‐induced upregulation of IL‐7 receptor (IL‐7R) expression, leading to increased pro‐survival signalling. IL‐7R reaches the cell surface via the secretory pathway, so we hypothesized that inhibiting the translocation of IL‐7R into the secretory pathway would overcome GC resistance. Sec61 is an endoplasmic reticulum (ER) channel that is required for insertion of polypeptides into the ER. Here, we demonstrate that KZR‐445, a novel inhibitor of Sec61, potently attenuates the dexamethasone (DEX)‐induced increase in cell surface IL‐7R and overcomes IL‐7‐induced DEX resistance.
- Subjects
LYMPHOBLASTIC leukemia; ACUTE leukemia; T cells; GLUCOCORTICOIDS; PROGNOSIS
- Publication
British Journal of Haematology, 2022, Vol 198, Issue 1, p137
- ISSN
0007-1048
- Publication type
Article
- DOI
10.1111/bjh.18181